| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/28/2008 | WO2008024423A2 4-thio substituted quinoline and naphthyridine compounds |
| 02/28/2008 | WO2008024409A1 Progenitor cell replication and differentiation in 3d |
| 02/28/2008 | WO2008024390A2 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders |
| 02/28/2008 | WO2008024374A2 Inhibitors of pancreatic phospholipase a2 for altering cholesterol and fat uptake |
| 02/28/2008 | WO2008024364A2 Heterocyclic compounds as sweetener enhancers |
| 02/28/2008 | WO2008024355A2 Suppression of estrus in mares by a single injection method |
| 02/28/2008 | WO2008024305A2 Bis (thiohydrazide amides) for treating melanoma |
| 02/28/2008 | WO2008024304A2 Compounds for treatment of proliferative disorders |
| 02/28/2008 | WO2008024303A2 Compounds for treating proliferative disorders |
| 02/28/2008 | WO2008024302A2 Compounds for treating proliferative disorders |
| 02/28/2008 | WO2008024301A2 Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma |
| 02/28/2008 | WO2008024299A2 Combination with bis(thiohydrazide amides) for treating cancer |
| 02/28/2008 | WO2008024298A1 Bis(thiohydrazide amides) for inhibiting angiogenesis |
| 02/28/2008 | WO2008024284A2 Sulfonylated piperazines as cannabinoid-1 receptor modulators |
| 02/28/2008 | WO2008024277A2 Kw-3902 conjugates that do not cross the blood-brain barrier |
| 02/28/2008 | WO2008024196A1 Chemical compounds |
| 02/28/2008 | WO2008024151A2 Salts and co-crystals of pyrazolopyrimidine compounds, compositions thereof and methods for their production and use |
| 02/28/2008 | WO2008024143A2 Process for the synthesis of (+) and (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane |
| 02/28/2008 | WO2008024139A2 Inhibitors of fatty acid amide hydrolase |
| 02/28/2008 | WO2008024045A1 Compositions, suitable for oral administration, comprising a triazolo [4, 5-d]pyrimidin derivate |
| 02/28/2008 | WO2008024044A1 Compositions, suitable for oral administration, comprising a triazolo [4, 5] pyrimidin derivate |
| 02/28/2008 | WO2008024029A1 Substituted azepino[4,3-b]indoles, pharmacological composition and a method for the production and use thereof |
| 02/28/2008 | WO2008024026A2 Use of 9-oxoacridine-10-acetic acid, its salts and esters for the treatment, prophylaxis or relapse prevention of prostate cancer |
| 02/28/2008 | WO2008024021A1 Antioxidant for preventing and treating diseases caused by oxidative stress |
| 02/28/2008 | WO2008024020A1 Liposomal composition of antioxidants for inhalations carried out during lung and upper respiratory tract diseases |
| 02/28/2008 | WO2008023998A1 N-acylethanolamines as wound healing agents |
| 02/28/2008 | WO2008023966A1 Novel use of panduratin a or derivatives thereof |
| 02/28/2008 | WO2008023869A1 Combined pharmeceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitors |
| 02/28/2008 | WO2008023847A1 P2x4 receptor antagonist |
| 02/28/2008 | WO2008023807A1 Stabilized pharmaceutical composition |
| 02/28/2008 | WO2008023796A1 Proteoglycan production accelerator |
| 02/28/2008 | WO2008023784A1 Agent for amelioration of ophthalmic circulatory disorder |
| 02/28/2008 | WO2008023783A1 Amine compound |
| 02/28/2008 | WO2008023725A1 Preventive and/or therapeutic agent for peripheral neuropathy |
| 02/28/2008 | WO2008023720A1 Urea compound or salt thereof |
| 02/28/2008 | WO2008023698A1 Salt of phenoxypyridine derivative or crystal thereof and process for producing the same |
| 02/28/2008 | WO2008023455A1 Tyrosinase inhibitor |
| 02/28/2008 | WO2008023446A1 Remedy for chronic obstructive pulmonary disease |
| 02/28/2008 | WO2008023389A1 A hormonal intrauterine device for delivery of levonorgestrel |
| 02/28/2008 | WO2008023384A1 Propofol emulsion compositions for intravenous administration |
| 02/28/2008 | WO2008023364A1 Inhibition of ornithine aminotransferase for the treatment of proliferative disorders |
| 02/28/2008 | WO2008023362A2 Use of a combination of methotrexate and an a3ar agonist for the treatment of cancer |
| 02/28/2008 | WO2008023357A1 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr) |
| 02/28/2008 | WO2008023336A2 Matrix metalloproteinase inhibitors |
| 02/28/2008 | WO2008023266A2 Kiwi extract |
| 02/28/2008 | WO2008023261A1 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic |
| 02/28/2008 | WO2008023258A1 Piperidine derivatives |
| 02/28/2008 | WO2008023248A2 Novel macrolides and ketolides having antimicrobial activity |
| 02/28/2008 | WO2008023239A1 Pyrimidone compounds as gsk-3 inhibitors |
| 02/28/2008 | WO2008023235A1 Pyrazole derivatives as anti-platelet and anti-thrombotic agents |
| 02/28/2008 | WO2008023213A1 Bile acid sequestrant and process for preparation thereof |
| 02/28/2008 | WO2008023184A2 Solid dosage form |
| 02/28/2008 | WO2008023180A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 02/28/2008 | WO2008023161A1 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors |
| 02/28/2008 | WO2008023159A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 02/28/2008 | WO2008023157A1 Nitrogen containing heterocyclic compounds useful as m3-receptor modulators |
| 02/28/2008 | WO2008023066A1 Imidazole compounds having an antiinflammatory effect |
| 02/28/2008 | WO2008023016A2 Galenic formulations of aliskiren |
| 02/28/2008 | WO2008023005A1 Aerosol formulation for the inhalation of beta-agonists |
| 02/28/2008 | WO2008023004A1 Single enantiomer beta agonists method for production and use thereof as a medicament |
| 02/28/2008 | WO2008023003A1 Drug combinations for treating airway diseases |
| 02/28/2008 | WO2008023001A1 Powder formulations for inhalation containing enantiomerically pure beta-agonists |
| 02/28/2008 | WO2008022994A1 Use of azabicyclo hexane derivatives |
| 02/28/2008 | WO2008022979A1 New pyridone derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 02/28/2008 | WO2008022976A1 Synthesis, polymorphs, and pharmaceutical formulation of a faah inhibitor |
| 02/28/2008 | WO2008022974A2 Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof |
| 02/28/2008 | WO2008022938A1 Di-aromatic substituted amides as inhibitors for glyt1 |
| 02/28/2008 | WO2008022932A2 Controlled release system and method for manufacturing the same |
| 02/28/2008 | WO2008022807A2 Lipoxin a4 analogs for the treatment and prevention of intestinal fibrosis |
| 02/28/2008 | WO2008022786A1 Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders |
| 02/28/2008 | WO2008022784A2 Long-lasting absorption of flavonoids |
| 02/28/2008 | WO2008022771A1 Amides as sphingomyeline inhibitors |
| 02/28/2008 | WO2008022761A2 Rapamycin and its derivatives for the treatment of liver-associated fibrosing disorders |
| 02/28/2008 | WO2008022747A1 Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
| 02/28/2008 | WO2008022725A1 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral disorders |
| 02/28/2008 | WO2008022557A1 Liquid composition of sirolimus |
| 02/28/2008 | WO2008022541A1 Water-soluble derivatives of anesthetic 2,6-diisopropylphenol and preparation method thereof |
| 02/28/2008 | WO2008022535A1 A pharmaceutical composition for treating brain glioma, its process and pharmaceutical preparation |
| 02/28/2008 | WO2008022505A1 Use of rubescensine a and derivatives thereof in pharmacy |
| 02/28/2008 | WO2008022468A1 Compositions and methods for treating myelosuppression |
| 02/28/2008 | WO2008022462A1 Para-quinol derivatives and methods of stereo selectively synthesizing and using same |
| 02/28/2008 | WO2008022422A1 Pharmaceutical compositions for the treatment of tripanossomiasis and chagas disease |
| 02/28/2008 | WO2008022396A1 Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 02/28/2008 | WO2008011485A3 Methods for treating chronic pain |
| 02/28/2008 | WO2008011113A3 Thiadiazolidinone derivatives |
| 02/28/2008 | WO2008009335A3 Aminoindazole urea derivatives |
| 02/28/2008 | WO2008008821A3 Use of trifluoromethyl substituted benzamides in the treatment of neurological disorders |
| 02/28/2008 | WO2008008701A3 Substituted cyclopentane derivatives as therapeutic agents |
| 02/28/2008 | WO2008008700A3 Substituted cyclopentane derivatives as therapeutic agents |
| 02/28/2008 | WO2008007123A3 Pharmaceutical compounds |
| 02/28/2008 | WO2008006979A3 Process for preparing diaminophenothiazinium compounds |
| 02/28/2008 | WO2008006883A3 Benzopyranopyrazoles |
| 02/28/2008 | WO2008006589A3 Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders |
| 02/28/2008 | WO2008006295B1 New optical active phenylethanol amines and preparing method thereof |
| 02/28/2008 | WO2008006113A3 Novel belactosin derivatives as therapeutic agents/biological probes and their synthesis |
| 02/28/2008 | WO2008003013A3 Antitumorigenic drug combination comprising an hdac inhibitor and a tsp-1 peptidomimetic |
| 02/28/2008 | WO2008002573A3 Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions |
| 02/28/2008 | WO2008000744A3 2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor |
| 02/28/2008 | WO2008000692A3 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity |
| 02/28/2008 | WO2008000448A3 Nanostructured lipid carriers containing riluzole and pharmaceutical formulations containing said particles |